Log In
|
Recently Purchased
|
Favorites
|
My COAs
|
Cart
(0)
OVERVIEW
INNOVATIONS
COMPANY PROFILE
OUR EXPERTS
FACILITY
OVERVIEW
QUALITY CREDENTIALS
COA EXAMPLES
EXPIRY/RETEST DATES
OVERVIEW
SYNTHESIS
CERTIFIED SOLUTION
STANDARDS
CERTIFICATIONS
PACKAGING
INVENTORY MANAGEMENT
& DISTRIBUTION
OEM & PRIVATE LABEL
REQUEST QUOTE
CATALOG
NEW PRODUCTS
ORDERING INFORMATION
REQUEST/DOWNLOAD
CATALOG
REQUEST CUSTOM QUOTE
SEARCH COAs/SDSs
PAPERS & POSTER
PRESENTATIONS
CONTACT INFORMATION
INTERNATIONAL SALES
CAREERS
LOG IN/REQUEST LOGIN
FAVORITES
RECENTLY PURCHASED
QUICK ORDER
ORDER HISTORY
PURCHASES BY ITEM
MY ACCOUNT'S COAs & SDSs
VIEW CART/CHECK OUT
Evaluation of LCMSMS Deuterium Scrambling in Clinically Significant Small Molecules
Authors:
Joshua Cooper, IsilDilek, UmaSreenivasan
Presented at
Mass Spectrometry Application to the Clinical Lab (MSACL), San Diego, CA, January 2012
Abstract
LC-MS/MS is a powerful tool that brings numerous benefits to the clinical sample analysis arena. However, due to the complexity of the instrumentation there are some unique challenges that also accompany these benefits. Even following sample extraction and cleanup, matrix effects from the samples can cause interferences or impact ionization efficiency. Deuterium-labeled internal standards are the most common and prevalent labeled internal standards used to compensate for matrix effects. Some deuterium labeled compounds may exhibit hydrogen-deuterium scrambling/exchange in the collision cell which can impact MS/MS transition selection.
view poster
return to papers and poster presentations
©
2024
Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
MilliporeSigma is a business of Merck KGaA, Darmstadt, Germany
Products
|
Sitemap
|
Privacy Policy
|
EHS Policy
|
Terms & Conditions
|
Contact